Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2.

Saved in:
Bibliographic Details
Title: Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2.
Authors: Wichmann CW; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Guo N; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Rigopoulos A; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia., McDonald A; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Cao D; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia., O'Keefe GJ; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia., Gong SJ; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia; School of Engineering and Mathematical Sciences, La Trobe University, Australia., Gan HK; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Scott FE; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia., Pore N; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA., Coats S; Medimmune LLC, Gaithersburg, MD, USA., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.
Source: Nuclear medicine and biology [Nucl Med Biol] 2023 Jul-Aug; Vol. 122-123, pp. 108366. Date of Electronic Publication: 2023 Jul 14.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9304420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9614 (Electronic) Linking ISSN: 09698051 NLM ISO Abbreviation: Nucl Med Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37473513
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wichmann+CW%22">Wichmann CW</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Burvenich+IJG%22">Burvenich IJG</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Guo+N%22">Guo N</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Rigopoulos+A%22">Rigopoulos A</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22McDonald+A%22">McDonald A</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Cao+D%22">Cao D</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22O'Keefe+GJ%22">O'Keefe GJ</searchLink>; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Gong+SJ%22">Gong SJ</searchLink>; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia; School of Engineering and Mathematical Sciences, La Trobe University, Australia.<br /><searchLink fieldCode="AU" term="%22Gan+HK%22">Gan HK</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Scott+FE%22">Scott FE</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Pore+N%22">Pore N</searchLink>; Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Coats+S%22">Coats S</searchLink>; Medimmune LLC, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Scott+AM%22">Scott AM</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Melbourne, Australia; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229304420%22">Nuclear medicine and biology</searchLink> [Nucl Med Biol] 2023 Jul-Aug; Vol. 122-123, pp. 108366. <i>Date of Electronic Publication: </i>2023 Jul 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9304420 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-9614 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209698051%22">09698051 </searchLink><i>NLM ISO Abbreviation: </i>Nucl Med Biol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37473513
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.nucmedbio.2023.108366
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108366
    Titles:
      – TitleFull: Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wichmann CW
      – PersonEntity:
          Name:
            NameFull: Burvenich IJG
      – PersonEntity:
          Name:
            NameFull: Guo N
      – PersonEntity:
          Name:
            NameFull: Rigopoulos A
      – PersonEntity:
          Name:
            NameFull: McDonald A
      – PersonEntity:
          Name:
            NameFull: Cao D
      – PersonEntity:
          Name:
            NameFull: O'Keefe GJ
      – PersonEntity:
          Name:
            NameFull: Gong SJ
      – PersonEntity:
          Name:
            NameFull: Gan HK
      – PersonEntity:
          Name:
            NameFull: Scott FE
      – PersonEntity:
          Name:
            NameFull: Pore N
      – PersonEntity:
          Name:
            NameFull: Coats S
      – PersonEntity:
          Name:
            NameFull: Scott AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2023 Jul-Aug
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1872-9614
          Numbering:
            – Type: volume
              Value: 122-123
          Titles:
            – TitleFull: Nuclear medicine and biology
              Type: main
ResultId 1